Combined first-trimester screening for Down's syndrome warranted

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.410, 2003-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costs associated with triple screening for Down's syndrome

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Early First-Trimester Sibutramine Exposure: Pregnancy Outcome and Neonatal Follow-Up

By Marco De Santis   Straface Gianluca   Cavaliere Anna F.   Carducci Brigida   Caruso Alessandro  

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 255-259

Adis International

Access to resources Recommend Favorite

Which Down's syndrome screening option best in Canada?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 573, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Down's syndrome screening in pregnancies after assisted reproductive techniques: an update

By Maymon Ron   Jauniaux Eric  

Reproductive BioMedicine Online, Vol. 4, Iss. 3, 2002-05 ,pp. : 285-293

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Screening men for abdominal aortic aneurysm warranted in the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 390, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite